CtrlK
Neurocrine Biosciences
NBIX86
$105.76arrow_drop_up2.40%$2.48
NASDAQ - As of Apr 29, 7:10 AM EDT Market Closed
High Quality
High Growth
NBIX86
$105.76
arrow_drop_up2.40%Performance History
There's no data available for performance history chart
| Key Stats | |
|---|---|
| Open | $103.17 |
| Prev. Close | $103.22 |
| EPS | 3.29 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $8.99B |
| PE Ratio | 32.15 |
| LOW | HIGH | |
|---|---|---|
| Day Range | 100.95 | 105.84 |
| 52 Week Range | 87.75 | 157.98 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
There's no data available for Analyst Forecast
Period: -
• Predicted: -Analyst Ratings
There's no data available for Analyst Ratings
Last updated: -
• Total: -Correlated Companies
About Neurocrine Biosciences (NBIX)
- Sector
- Healthcare
- Industry
- Drug Manufacturers—Specialty & Generic
- CEO
- Dr. Kevin C. Gorman Ph.D.
- Headquarters
- San Diego
- Employees
- 1300
- Exchange
- NASDAQ
Keep an eye on Neurocrine Biosciences
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Neurocrine Biosciences 's (NBIX) price per share?
The current price per share for Neurocrine Biosciences (NBIX) is $105.76. The stock has seen a price change of $2.48 recently, indicating a 2.4% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Neurocrine Biosciences (NBIX)?
For Neurocrine Biosciences (NBIX), the 52-week high is $157.98, which is 49.38% from the current price. The 52-week low is $87.76, the current price is 20.51% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Neurocrine Biosciences (NBIX) a growth stock?
Neurocrine Biosciences (NBIX) has shown an average price growth of -1.65% over the past three years. It has received a score of 66 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Neurocrine Biosciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Neurocrine Biosciences (NBIX) stock price performance year to date (YTD)?
As of the latest data, Neurocrine Biosciences (NBIX) has a year-to-date price change of -22.52%. Over the past month, the stock has experienced a price change of -8.51%. Over the last three months, the change has been -28.34%. Over the past six months, the figure is -8.1%. Looking at a longer horizon, the five-year price change stands at 11.44%.
help
Is Neurocrine Biosciences (NBIX) a profitable company?
Neurocrine Biosciences (NBIX) has a net income of $341.3M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 20.87% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $2.36B, with a revenue growth rate of 24.81%, providing insight into the company's sales performance and growth. The gross profit is $2.32B. Operating income is noted at $570.5M. Furthermore, the EBITDA is $588.9M.
help
What is the market capitalization of Neurocrine Biosciences (NBIX)?
Neurocrine Biosciences (NBIX) has a market capitalization of $8.99B. The average daily trading volume is 105.01, indicating the stock's liquidity and investor engagement.